Flexible bronchoscopy in children and adolescents with cystic fibrosis
Conclusions: FB was performed in almost one third of children and adolescents with CF. Exacerbations’ evaluation and eradication treatment surveillance were the most frequent reasons for bronchoscopic evaluation. No adverse events were encountred.
Condition: Nonalcoholic Fatty Liver Disease Interventions: Behavioral: Guided Grocery Shopping (GGS); Other: Diet Provision Group Sponsors: Emory University; Center for Cystic Fibrosis and Airways Disease Research Not yet recruiting
Condition: Cystic Fibrosis Interventions: Other: Autogenic drainage; Device: SIMEOX + Autogenic drainage Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain Recruiting
AbstractThe contribution of T-cells after lung transplant (LTx) remains controversial with no current consensus of their role concerning chronic lung allograft dysfunction. Using flow cytometry to assess T-cell subsets of bronchoalveolar lavage fluid (BALF) in 16 cystic fibrosis (CF) LTx recipients, we identified a decline in CD4+ T-cell frequency and an increase in CD8+ T-cell frequency in patients who developed severe bronchiolitis obliterans syndrome (BOS) (N = 10) when comparing baseline (6 months post-LTx) and follow-up (most recent bronchoscopy—clinical or surveillance per protocol). Comparin...
ConclusionsThe synbiotic had no significant effect on pulmonary and anthropometric outcomes in children with CF. Further studies are necessary to confirm these findings.
For the past four years, a research session at the annual European Cystic Fibrosis Society (ECFS) meeting has been co-hosted by The Lancet Respiratory Medicine and the Journal of Cystic Fibrosis. At the 2020 ECFS meeting in June in Lyon, France, we are pleased to announce that the European Respiratory Journal will join this session for the first time.
Condition: Cystic Fibrosis Interventions: Drug: ELX/TEZ/IVA; Drug: IVA Sponsor: Vertex Pharmaceuticals Incorporated Not yet recruiting
Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.9b01416
All-cause mortality risk and causes of death in bronchiectasis patients have not been fully investigated. The aim of this study was to compare the mortality risk and causes of death between individuals with br...
‘First step’ to better outcomes for cystic fibrosis Related items fromOnMedica Lung experts call for ‘national plan for lung cancer’ Smokers ’ lungs should remain as transplant option COPD patients need better tailored care Antibiotic fails to improve lung function in children with CF Sweet and fruity e-cigs linked to prolonged teenage vaping
We present an alternative method for the identification of CF by combining desorption electrospray ionization mass...